Over the last 7 days, the Biotech industry has dropped 1.4%, driven by a pullback from Polaris Group of 5.2%. This takes the industry's 12 month performance to a gain of 13%. Earnings are forecast to grow by 70% annually.
Has the Taiwanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 25 Jul 2024 | NT$572.0b | NT$21.9b | -NT$11,110,100,000.00 | 42.4x | -51.5x | 26.1x |
Sat, 22 Jun 2024 | NT$517.8b | NT$21.9b | -NT$11,110,643,000.00 | 41.9x | -46.6x | 23.6x |
Mon, 20 May 2024 | NT$489.9b | NT$21.9b | -NT$10,954,603,000.00 | 39.6x | -44.7x | 22.3x |
Wed, 17 Apr 2024 | NT$448.0b | NT$20.8b | -NT$12,155,400,000.00 | 49.2x | -36.9x | 21.5x |
Fri, 15 Mar 2024 | NT$435.6b | NT$20.7b | -NT$9,966,695,000.00 | 42.8x | -43.7x | 21.1x |
Sun, 11 Feb 2024 | NT$436.3b | NT$19.9b | -NT$9,857,794,000.00 | 40.5x | -44.3x | 21.9x |
Tue, 09 Jan 2024 | NT$465.9b | NT$19.8b | -NT$9,748,146,000.00 | 39.2x | -47.8x | 23.6x |
Thu, 07 Dec 2023 | NT$478.9b | NT$19.9b | -NT$9,737,975,000.00 | 43.2x | -49.2x | 24.1x |
Sat, 04 Nov 2023 | NT$470.8b | NT$18.4b | -NT$10,823,013,000.00 | 49.3x | -43.5x | 25.5x |
Mon, 02 Oct 2023 | NT$477.3b | NT$18.3b | -NT$10,774,226,000.00 | 43.3x | -44.3x | 26.1x |
Wed, 30 Aug 2023 | NT$482.3b | NT$18.3b | -NT$10,598,878,000.00 | 41.7x | -45.5x | 26.3x |
Fri, 28 Jul 2023 | NT$471.0b | NT$18.7b | -NT$10,724,655,000.00 | 44.1x | -43.9x | 25.2x |
Sun, 25 Jun 2023 | NT$470.5b | NT$18.7b | -NT$10,709,428,000.00 | 42.6x | -43.9x | 25.2x |
Tue, 23 May 2023 | NT$479.5b | NT$19.3b | -NT$9,957,876,000.00 | 43.3x | -48.2x | 24.9x |
Thu, 20 Apr 2023 | NT$538.7b | NT$18.5b | -NT$9,609,324,000.00 | 43.2x | -56.1x | 29.1x |
Sat, 18 Mar 2023 | NT$492.3b | NT$22.5b | -NT$7,203,089,000.00 | 36.9x | -68.3x | 21.9x |
Mon, 13 Feb 2023 | NT$532.0b | NT$21.8b | -NT$7,832,470,000.00 | 38x | -67.9x | 24.4x |
Wed, 11 Jan 2023 | NT$486.8b | NT$21.8b | -NT$7,778,690,000.00 | 35.9x | -62.6x | 22.3x |
Fri, 09 Dec 2022 | NT$522.8b | NT$21.8b | -NT$7,522,211,000.00 | 37.8x | -69.5x | 24x |
Sun, 06 Nov 2022 | NT$468.2b | NT$23.1b | -NT$6,633,590,000.00 | 37.4x | -70.6x | 20.3x |
Tue, 04 Oct 2022 | NT$508.4b | NT$23.1b | -NT$6,633,590,000.00 | 37.2x | -76.6x | 22x |
Thu, 01 Sep 2022 | NT$635.3b | NT$23.0b | -NT$6,443,294,000.00 | 43.7x | -98.6x | 27.6x |
Sat, 30 Jul 2022 | NT$566.7b | NT$22.5b | -NT$5,642,821,000.00 | 31.8x | -100.4x | 25.1x |
Mon, 27 Jun 2022 | NT$530.6b | NT$22.5b | -NT$5,642,821,000.00 | 32x | -94x | 23.5x |
Wed, 25 May 2022 | NT$493.7b | NT$22.5b | -NT$5,642,821,000.00 | 31.7x | -87.5x | 21.9x |
Fri, 22 Apr 2022 | NT$552.3b | NT$21.5b | -NT$5,726,696,000.00 | 35.1x | -96.4x | 25.7x |
Sun, 20 Mar 2022 | NT$504.9b | NT$20.0b | -NT$4,463,544,000.00 | 26.7x | -113.1x | 25.2x |
Tue, 15 Feb 2022 | NT$440.3b | NT$17.9b | -NT$5,532,702,000.00 | 25.2x | -79.6x | 24.6x |
Thu, 13 Jan 2022 | NT$440.7b | NT$17.9b | -NT$5,532,702,000.00 | 26.1x | -79.6x | 24.6x |
Sat, 11 Dec 2021 | NT$443.3b | NT$17.9b | -NT$5,579,296,000.00 | 23.6x | -79.4x | 24.7x |
Mon, 08 Nov 2021 | NT$357.3b | NT$15.4b | -NT$7,624,179,000.00 | 21.1x | -46.9x | 23.2x |
Wed, 06 Oct 2021 | NT$344.8b | NT$15.4b | -NT$7,624,179,000.00 | 20.4x | -45.2x | 22.4x |
Fri, 03 Sep 2021 | NT$381.7b | NT$15.4b | -NT$7,624,179,000.00 | 20.8x | -50.1x | 24.8x |
Sun, 01 Aug 2021 | NT$394.2b | NT$15.4b | -NT$7,624,179,000.00 | 21.6x | -51.7x | 25.6x |
-51.7x
Which industries have driven the changes within the Taiwanese Healthcare industry?
TW Market | -3.84% | |
Healthcare | -2.86% | |
Biotech | -1.35% | |
Biotech | -1.35% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6446 PharmaEssentia | NT$658.00 | 2.0% +NT$4.3b | 94.1% | PE494.1x | |
4728 Sunmax Biotechnology | NT$296.50 | 4.0% +NT$626.3m | 47.5% | PE24x | |
4726 Mycenax Biotech | NT$60.90 | 2.5% +NT$308.7m | 37.8% | PS21.1x | |
6955 Bonraybio | NT$154.00 | 6.7% +NT$189.7m | 114.9% | n/a | |
4142 Adimmune | NT$29.50 | 1.0% +NT$126.5m | -16.2% | PS7.5x |